- United Kingdom - Solicitors
- United Kingdom - The Bar
- United States
- Canada
- Caribbean
- Deutschland
- Paris
- Tax Directors Handbook
THE LEGAL 500'S GUIDE TO AUSTRALIA'S RISING STARS
- The Lex 100
- Firms in the spotlight
- Interviews with
- What is The Legal 500?
- Meet the team
- How can my law firm get involved?
- Research calendar
- The Legal 500 on Twitter
- Contact us
- Other Legalease products
ABOUT US
AVAILABLE NOW...
GC Powerlist:
Iberia Teams 2019
INTERNATIONAL ARBITRATION POWERLIST
UNITED KINGDOM
- The Legal Business Awards
- Enterprise GC
- The Legal 500 UK Awards 2019
- The changing role of in-house counsel in Europe
- The Legal 500's Guide to Australia's Rising Stars
- Middle East Disputes Summit 2019
- The Legal Business Global London Roundtable Dinner 2019
- Doing business in Central America
- GC Summit Russia
- The development of Colombian compliance and anti-corruption legislation
- Cost-effective arbitration in Kuwait
- European GC's use of tech - AI Special
- The quantum of equality – The women lawyers redefining disputes
- Crisis prevention and management roundtable in Shanghai
- Legal Business 100 Roundtable
- Legal Business Legal Technology Roundtable
- Leadership insight
- Human rights insight
- MINT: the legal challenges of working and investing in emerging economies
- Response to Brexit
- An investigation of the GCC and Middle East legal market
- Litigation and regulatory challenges in financial services
- AI and the law tools of tomorrow:
A special report - Scottish GCs
- North West clients
- COMPANIES
- Weil, Gotshal & Manges LLP
- Baker McKenzie
- DLA Piper
- World Services Group
- Eversheds Sutherland
- RPC
- Clifford Chance
- KPMG
- PayPal
- GC DIVERSITY AND INCLUSION REPORTS
- Shaping diversity
- A Numbers Game: Diversity in Europe
- Barbara Levi Mager describes Sandoz's approach to diversity
- Louise Pentland discusses putting diversity front and centre at PayPal
- Prash Naik (Channel 4) talks about the 360° Diversity Charter
- Ian Johnson explains the strategic importance of inclusive work environments
Search News and Articles
Bär & Karrer Advises Swedish Orphan Biovitrum AB in the Acquisition of emapalumab
Swedish Orphan Biovitrum AB, an international specialty biopharmaceutical company listed in Sweden, agreed to acquire, from Novimmune’s shareholders, a newly established company owning emapalumab and related assets, giving Sobi access to world-class R&D capabilities in the field of Immunology. The acquisition supersedes the previously announced exclusive licence agreement with Novimmune. In addition, Sobi agreed with Novimmune on options for the shared financial rights to NI-1701 and NI-1801, two product candidates in the field of immuno-oncology. The transaction value is CHF 515 million, of which CHF 400 million was previously committed in the exclusive license agreement for emapalumab.
Bär & Karrer acted as legal advisor to Swedish Orphan Biovitrum AB (publ). The team included Urs Brügger, Marc Poltéra, Raphael Wyss, Eliane Albert and Michael Neumann (all M&A and Corporate), Markus Schott (Regulatory), Laura Widmer (Employment), Jonas Bornhauser (IP) as well as Mani Reinert (Competition Law).